INOVIO PHARMACEUTICALS, INC. Earnings Per Share Diluted

• INOVIO PHARMACEUTICALS, INC. showed an increase of +54.2% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from INOVIO PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2013: $0.23 (loss) per share | Q2 2013: $0.24 (loss) per share | Q3 2013: $0.64 (loss) per share | Q4 2013: $0.30 (loss) per share | Q1 2014: $0.20 (loss) per share | Q2 2014: $0.19 (loss) per share | Q3 2014: $0.12 (loss) per share | Q4 2014: $0.12 (loss) per share | Q1 2015: $0.18 (loss) per share | Q2 2015: $0.09 (loss) per share | Q3 2015: $0.07 per share | Q4 2015: $0.25 (loss) per share | Q1 2016: $0.11 (loss) per share | Q2 2016: $0.26 (loss) per share | Q3 2016: $0.28 (loss) per share | Q4 2016: $0.36 (loss) per share | Q1 2017: $0.31 (loss) per share | Q2 2017: $0.13 (loss) per share | Q3 2017: $0.40 (loss) per share | Q4 2017: $0.24 (loss) per share | Q1 2018: $0.36 (loss) per share | Q2 2018: $0.08 (loss) per share | Q3 2018: $0.27 (loss) per share | Q4 2018: $0.34 (loss) per share | Q1 2019: $0.30 (loss) per share | Q2 2019: $0.30 (loss) per share | Q3 2019: $0.25 (loss) per share | Q4 2019: $0.38 (loss) per share | Q2 2020: $0.83 (loss) per share | Q3 2020: $0.11 per share | Q1 2021: $0.27 (loss) per share | Q2 2021: $0.39 (loss) per share | Q3 2021: $0.29 (loss) per share | Q1 2022: $0.36 (loss) per share | Q2 2022: $0.46 (loss) per share | Q3 2022: $0.15 (loss) per share | Q1 2023: $1.89 (loss) per share | Q2 2023: $1.61 (loss) per share | Q3 2023: $1.52 (loss) per share | Q1 2024: $1.31 (loss) per share | Q2 2024: $1.19 (loss) per share | Q3 2024: $0.89 (loss) per share | Q1 2025: $0.51 (loss) per share | Q2 2025: $0.61 (loss) per share | Q3 2025: $0.87 (loss) per share.
• Over the full 14 years of available data (2012 to 2025), INOVIO PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has declined by 212.1%.
• Historical annual values: Fiscal year 2025: $1.81 (loss) per share | Fiscal year 2024: $3.95 (loss) per share | Fiscal year 2023: $6.09 (loss) per share | Fiscal year 2022: $14.07 (loss) per share | Fiscal year 2021: $17.45 (loss) per share | Fiscal year 2020: $1.07 (loss) per share | Fiscal year 2019: $1.21 (loss) per share | Fiscal year 2018: $1.05 (loss) per share | Fiscal year 2017: $1.09 (loss) per share | Fiscal year 2016: $1.01 (loss) per share | Fiscal year 2015: $0.44 (loss) per share | Fiscal year 2014: $0.64 (loss) per share | Fiscal year 2013: $1.43 (loss) per share | Fiscal year 2012: $0.58 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026